The global PCR and realtime PCR testing market is expected to decline from $22.53 billion in 2020 to $9.98 billion in 2021 at a compound annual growth rate (CAGR) of -55.7%. The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to reach $13.82 billion in 2025 at a CAGR of 8.5%.
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics) Read More @ https://bit.ly/33Znn41
The global PCR and realtime PCR testing market is expected to decline from $22.53 billion in 2020 to $9.98 billion in 2021 at a compound annual growth rate (CAGR) of -55.7%.
The rise in the prevalence of hematologic cancer, increment in knowledge of precision medicine and the increase in the amount of assays are likely to result in the rapid growth of the oncology research industry in the forecast years.
... and tracks functional recovery, and tests and challenges existing theories of rehabilitation. ... to adapt to this framework for backwards-compatibility ...
On the basis of product and service, the dPCR and qPCR market is categorized into instruments; reagents and consumables; and software and services. Download Sample at http://bit.ly/2u5yvdz . The dPCR instruments segment is expected to witness the highest growth during the forecast period.The growth of this segment is mainly due to the procedural benefits of dPCR over qPCR, growing market demand for dPCR procedures (particularly in forensics and drug discovery), and rising number of dPCR-based researches across the globe.